DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)
DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)
Recruiting · NCT05966064 · Registry updated 2025-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) | Bone Diseases, Developmental, bone disorder, fibrous dysplasia, musculoskeletal system disorder, osteochondrodysplasia, polyostotic fibrous dysplasia | Recruiting | Phase 4 | 2025-01-29 | NCT05966064 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Natasha Appelman-Dijkstra | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Leiden University Medical Center | Leiden | Netherlands | 54 |